Casa Di Cura Accreditata Istituto Chirurgico Ortopedico Traumatologico Marco Pasquali

The medical center is at the forefront of cardiovascular research, focusing on innovative approaches to prevent major adverse cardiovascular events. The center's work in this field is exemplified by its study on the efficacy of inclisiran in reducing the risk of significant cardiovascular incidents in high-risk patients.

• Prevention of Atherosclerotic Cardiovascular Disease (ASCVD)
• Reduction of Major Adverse Cardiovascular Events (MACE)
• Innovative Lipid-Lowering Therapies

Through its research, the center contributes to the development of new therapeutic strategies aimed at improving cardiovascular health and reducing the burden of heart disease globally.

Specializing in oncology, the medical center is dedicated to advancing the treatment of metastatic prostate cancer. The center's research includes evaluating the effectiveness of combining surgical treatment with novel therapies such as apalutamide to improve patient outcomes.

• Advanced Prostate Cancer Management
• Integration of Novel Therapeutics
• PSMA-PET Imaging in Cancer Staging

By exploring cutting-edge treatment combinations, the center aims to enhance survival rates and quality of life for patients with high-risk prostate cancer.